TapewireFind a company

organization · Reporting owner

Reprogrammed Interchange LLC

Disclosed activity across 1 company

Tapewire entity
74105
SEC CIK
0002050755

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Vor Biopharma Inc.VOR · Entity 476310% ownerOctober 17, 2025October 21, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Vor Biopharma Inc.

Report date October 17, 2025 · Filed October 21, 2025

Jointly reported with Hoffman Reid

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect1,166,909 Last balance in matching sequence After 2025-10-21 transaction · row 4 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rows

Row 1 · 2025-10-17 · Sale · Disposed 24,689 · Balance 1,179,753

F1: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Row 2 · 2025-10-17 · Sale · Disposed 1,028 · Balance 1,178,725

F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Row 3 · 2025-10-20 · Sale · Disposed 11,616 · Balance 1,167,109

F3: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Row 4 · 2025-10-21 · Sale · Disposed 200 · Balance 1,166,909

F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

F3: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
October 21, 2025 Filed Oct 21, 2025 17:45 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 200 $30.08 $6,015.00
Disclosure

SEC source: 0002050755-25-000019 · form4-10212025_091058.xml · nonDerivative · entry 4

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,166,909

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 20, 2025 Filed Oct 21, 2025 17:45 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 11,616 $30.05 $349,101.46
Disclosure

SEC source: 0002050755-25-000019 · form4-10212025_091058.xml · nonDerivative · entry 3

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,167,109

F3 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 17, 2025 Filed Oct 21, 2025 17:45 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 1,028 $31.00 $31,868.00
Disclosure

SEC source: 0002050755-25-000019 · form4-10212025_091058.xml · nonDerivative · entry 2

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,178,725

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 17, 2025 Filed Oct 21, 2025 17:45 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 24,689 $30.22 $746,118.86
Disclosure

SEC source: 0002050755-25-000019 · form4-10212025_091058.xml · nonDerivative · entry 1

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,179,753

F1 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 16, 2025 Filed Oct 17, 2025 18:33 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 2,021 $30.45 $61,549.15
Disclosure

SEC source: 0002050755-25-000017 · form4-10172025_101057.xml · nonDerivative · entry 4

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,204,442

F5 · price: This transaction was executed in multiple trades at prices ranging from $30.05 to $30.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 18:33 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 7,894 $32.77 $258,712.43
Disclosure

SEC source: 0002050755-25-000017 · form4-10172025_101057.xml · nonDerivative · entry 3

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,206,463

F4 · price: This transaction was executed in multiple trades at prices ranging from $32.51 to $33.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 18:33 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 48,910 $32.05 $1,567,364.97
Disclosure

SEC source: 0002050755-25-000017 · form4-10172025_101057.xml · nonDerivative · entry 2

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,214,357

F3 · price: This transaction was executed in multiple trades at prices ranging from $31.51 to $32.505. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 18:33 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 14,851 $31.05 $461,117.61
Disclosure

SEC source: 0002050755-25-000017 · form4-10172025_101057.xml · nonDerivative · entry 1

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,263,267

F1 · price: This transaction was executed in multiple trades at prices ranging from $30.505 to $31.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 14, 2025 Filed Oct 15, 2025 18:32 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 33,668 $30.32 $1,020,786.83
Disclosure

SEC source: 0002050755-25-000015 · form4-10152025_101041.xml · nonDerivative · entry 4

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,278,118

F5 · price: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.86. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 13, 2025 Filed Oct 15, 2025 18:32 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 2,334 $33.09 $77,225.76
Disclosure

SEC source: 0002050755-25-000015 · form4-10152025_101041.xml · nonDerivative · entry 3

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,311,786

F4 · price: This transaction was executed in multiple trades at prices ranging from $33.00 to $33.135. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 13, 2025 Filed Oct 15, 2025 18:32 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 19,672 $32.36 $636,560.35
Disclosure

SEC source: 0002050755-25-000015 · form4-10152025_101041.xml · nonDerivative · entry 2

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,314,120

F3 · price: This transaction was executed in multiple trades at prices ranging from $32.00 to $32.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 10, 2025 Filed Oct 15, 2025 18:32 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 40,983 $30.97 $1,269,132.86
Disclosure

SEC source: 0002050755-25-000015 · form4-10152025_101041.xml · nonDerivative · entry 1

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,333,792

F1 · price: This transaction was executed in multiple trades at prices ranging from $30.68 to $31.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 09, 2025 Filed Oct 10, 2025 17:51 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 15,042 $32.41 $487,439.02
Disclosure

SEC source: 0002050755-25-000013 · form4-10102025_091042.xml · nonDerivative · entry 4

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,374,775

F5 · price: This transaction was executed in multiple trades at prices ranging from $32.26 to $32.855. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 09, 2025 Filed Oct 10, 2025 17:51 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 33,842 $31.92 $1,080,172.34
Disclosure

SEC source: 0002050755-25-000013 · form4-10102025_091042.xml · nonDerivative · entry 3

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,389,817

F4 · price: This transaction was executed in multiple trades at prices ranging from $31.26 to $32.25. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 08, 2025 Filed Oct 10, 2025 17:51 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 14,336 $34.34 $492,285.34
Disclosure

SEC source: 0002050755-25-000013 · form4-10102025_091042.xml · nonDerivative · entry 2

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,423,659

F3 · price: This transaction was executed in multiple trades at prices ranging from $34.20 to $34.53. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 08, 2025 Filed Oct 10, 2025 17:51 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 60,926 $33.75 $2,056,471.83
Disclosure

SEC source: 0002050755-25-000013 · form4-10102025_091042.xml · nonDerivative · entry 1

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,437,995

F1 · price: This transaction was executed in multiple trades at prices ranging from $33.20 to $34.19. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 07, 2025 Filed Oct 8, 2025 17:20 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 27,624 $33.84 $934,710.53
Disclosure

SEC source: 0002050755-25-000011 · form4-10082025_091015.xml · nonDerivative · entry 4

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,498,921

F5 · price: This transaction was executed in multiple trades at prices ranging from $33.70 to $34.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 06, 2025 Filed Oct 8, 2025 17:20 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 18,156 $37.77 $685,830.19
Disclosure

SEC source: 0002050755-25-000011 · form4-10082025_091015.xml · nonDerivative · entry 3

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,526,545

F4 · price: This transaction was executed in multiple trades at prices ranging from $37.59 to $38.18 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 06, 2025 Filed Oct 8, 2025 17:20 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 34,847 $37.12 $1,293,565.94
Disclosure

SEC source: 0002050755-25-000011 · form4-10082025_091015.xml · nonDerivative · entry 2

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,544,701

F3 · price: This transaction was executed in multiple trades at prices ranging from $36.59 to $37.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 06, 2025 Filed Oct 8, 2025 17:20 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 17,760 $36.00 $639,391.97
Disclosure

SEC source: 0002050755-25-000011 · form4-10082025_091015.xml · nonDerivative · entry 1

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,579,548

F1 · price: This transaction was executed in multiple trades at prices ranging from $35.59 to $36.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 03, 2025 Filed Oct 3, 2025 21:12 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 4,701 $38.14 $179,316.82
Disclosure

SEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 8

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,597,308

F10 · price: This transaction was executed in multiple trades at prices ranging from $38.00 to $38.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 03, 2025 Filed Oct 3, 2025 21:12 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 3,200 $37.37 $119,593.92
Disclosure

SEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 7

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,602,009

F9 · price: This transaction was executed in multiple trades at prices ranging from $36.88 to $37.69. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 21:12 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 5,300 $42.32 $224,290.70
Disclosure

SEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 6

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,605,209

F8 · price: This transaction was executed in multiple trades at prices ranging from $42.00 to $42.70. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 21:12 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 13,001 $40.13 $521,706.73
Disclosure

SEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 5

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,610,509

F7 · price: This transaction was executed in multiple trades at prices ranging from $39.86 to $40.70. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 21:12 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 7,700 $39.57 $304,710.56
Disclosure

SEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 4

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,623,510

F6 · price: This transaction was executed in multiple trades at prices ranging from $39.20 to $39.84. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 21:12 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 1,513 $38.38 $58,064.55
Disclosure

SEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 3

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,631,210

F5 · price: This transaction was executed in multiple trades at prices ranging from $37.85 to $38.57. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 02, 2025 Filed Oct 3, 2025 21:12 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 4,937 $37.21 $183,684.54
Disclosure

SEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 2

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,632,723

F4 · price: This transaction was executed in multiple trades at prices ranging from $36.82 to $37.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 21:12 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 1,400 $39.19 $54,869.50
Disclosure

SEC source: 0002050755-25-000009 · form4-10042025_011012.xml · nonDerivative · entry 1

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,637,660

F1 · price: This transaction was executed in multiple trades at prices ranging from $39.11 to $39.415. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The number of shares beneficially owned reflects the 1-for-20 reverse stock split effected September 18, 2025.

F3 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
September 16, 2025 Filed Sep 18, 2025 20:40 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 447,278 $1.54 $688,852.85
Disclosure

SEC source: 0002050755-25-000008 · form4-09192025_120912.xml · nonDerivative · entry 1

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,781,209

F1 · price: This transaction was executed in multiple trades at prices ranging from $1.52 to $1.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
September 15, 2025 Filed Sep 15, 2025 17:17 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 400,000 $1.64 $656,320.00
Disclosure

SEC source: 0002050755-25-000007 · form4-09152025_090921.xml · nonDerivative · entry 3

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,228,487

F4 · price: This transaction was executed in multiple trades at prices ranging from $1.57 to $1.765. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
September 12, 2025 Filed Sep 15, 2025 17:17 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 300,000 $1.75 $526,230.00
Disclosure

SEC source: 0002050755-25-000007 · form4-09152025_090921.xml · nonDerivative · entry 2

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,628,487

F3 · price: This transaction was executed in multiple trades at prices ranging from $1.73 to $1.85. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
September 11, 2025 Filed Sep 15, 2025 17:17 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 284,805 $1.83 $521,420.99
Disclosure

SEC source: 0002050755-25-000007 · form4-09152025_090921.xml · nonDerivative · entry 1

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,928,487

F1 · price: This transaction was executed in multiple trades at prices ranging from $1.81 to $1.855. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
September 10, 2025 Filed Sep 10, 2025 20:27 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 350,000 $1.82 $635,285.00
Disclosure

SEC source: 0001415889-25-024198 · form4-09112025_120901.xml · nonDerivative · entry 3

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,213,292

F4 · price: This transaction was executed in multiple trades at prices ranging from $1.80 to $1.935. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
September 09, 2025 Filed Sep 10, 2025 20:27 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 449,226 $2.00 $898,631.69
Disclosure

SEC source: 0001415889-25-024198 · form4-09112025_120901.xml · nonDerivative · entry 2

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,563,292

F3 · price: This transaction was executed in multiple trades at prices ranging from $1.97 to $2.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
September 08, 2025 Filed Sep 10, 2025 20:27 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 464,421 $1.99 $924,058.46
Disclosure

SEC source: 0001415889-25-024198 · form4-09112025_120901.xml · nonDerivative · entry 1

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,012,518

F1 · price: This transaction was executed in multiple trades at prices ranging from $1.97 to $2.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
September 05, 2025 Filed Sep 5, 2025 18:51 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 400,000 $1.97 $787,280.00
Disclosure

SEC source: 0001415889-25-023821 · form4-09052025_100921.xml · nonDerivative · entry 3

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,476,939

F4 · price: This transaction was executed in multiple trades at prices ranging from $1.935 to $1.995. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
September 04, 2025 Filed Sep 5, 2025 18:51 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 453,016 $1.93 $873,641.36
Disclosure

SEC source: 0001415889-25-023821 · form4-09052025_100921.xml · nonDerivative · entry 2

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,876,939

F3 · price: This transaction was executed in multiple trades at prices ranging from $1.91 to $2.005. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
September 03, 2025 Filed Sep 5, 2025 18:51 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 554,612 $2.00 $1,107,061.01
Disclosure

SEC source: 0001415889-25-023821 · form4-09052025_100921.xml · nonDerivative · entry 1

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,329,955

F1 · price: This transaction was executed in multiple trades at prices ranging from $1.99 to $2.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
August 28, 2025 Filed Aug 29, 2025 18:05 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 806,351 $2.01 $1,621,975.04
Disclosure

SEC source: 0001415889-25-023318 · form4-08292025_100808.xml · nonDerivative · entry 2

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,884,567

F3 · price: This transaction was executed in multiple trades at prices ranging from $1.95 to $2.075. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
August 27, 2025 Filed Aug 29, 2025 18:05 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 611,647 $2.01 $1,226,535.73
Disclosure

SEC source: 0001415889-25-023318 · form4-08292025_100808.xml · nonDerivative · entry 1

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,690,918

F1 · price: This transaction was executed in multiple trades at prices ranging from $1.99 to $2.10. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
August 26, 2025 Filed Aug 27, 2025 17:25 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 284,190 $2.08 $591,342.55
Disclosure

SEC source: 0001415889-25-023165 · form4-08272025_090848.xml · nonDerivative · entry 2

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,302,565

F3 · price: This transaction was executed in multiple trades at prices ranging from $2.06 to $2.145. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
August 25, 2025 Filed Aug 27, 2025 17:25 UTC Vor Biopharma Inc. VOR · Entity 4763 SaleCommon Stock 387,346 $2.12 $819,740.34
Disclosure

SEC source: 0001415889-25-023165 · form4-08272025_090848.xml · nonDerivative · entry 1

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,586,755

F1 · price: This transaction was executed in multiple trades at prices ranging from $2.05 to $2.215. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
December 30, 2024 Filed Jan 2, 2025 19:42 UTC Vor Biopharma Inc. VOR · Entity 4763 PurchaseWarrant (Right to Buy) · Derivative 48,717,626 Not disclosed Strike: $0.84 Not disclosed
Disclosure

SEC source: 0001415889-25-000220 · form4-01032025_120101.xml · derivative · entry 2

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,717,626

Underlying: Common Stock · 48,717,626 shares

Expires 2031-12-30

F1 · price: Each share of Common Stock was purchased together with an accompanying Warrant to purchase 1.25 shares of Common Stock. The purchase price of the securities was $0.99425 per share and accompanying Warrant.

F3 · derivative.exercise_date: The Warrants are exercisable immediately. Notwithstanding the foregoing, the Reporting Persons shall not be entitled to exercise the Warrants to the extent that such exercise would cause the aggregate number of shares of Common Stock beneficially owned by the Reporting Person, their affiliates and any persons who are members of a Section 13(d) group with the Reporting Persons or their affiliates to exceed 9.99% of the total number of issued and outstanding shares of Common Stock of the Issuer following such exercise.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document
December 30, 2024 Filed Jan 2, 2025 19:42 UTC Vor Biopharma Inc. VOR · Entity 4763 PurchaseCommon Stock 38,974,101 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-000220 · form4-01032025_120101.xml · nonDerivative · entry 1

Reprogrammed Interchange LLC · CIK 0002050755 · 10% owner

Hoffman Reid · CIK 0001519339 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,974,101

F1 · price: Each share of Common Stock was purchased together with an accompanying Warrant to purchase 1.25 shares of Common Stock. The purchase price of the securities was $0.99425 per share and accompanying Warrant.

F2 · balance_after: The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.